39
Views
0
CrossRef citations to date
0
Altmetric
CASE REPORT

MAP2K1 K57N Conferred an Acquired Resistance to Furmonertinib, Dabrafenib and Trametinib Combined Therapy in Advanced Lung Adenocarcinoma with EGFR Mutation and BRAF V600E

, &
Pages 307-312 | Received 14 Dec 2023, Accepted 20 Mar 2024, Published online: 09 Apr 2024